Metraipolis › archive › dc_aaa2297dfed0

Long-Term Safety Profile of Ruxolitinib in Chronic Myeloproliferative Neoplasms: A Comprehensive Real-World Analysis — Europe PMC PMID:41169484

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41169484
DOI: 10.1002/jha2.70152
License (as archived): solo-consultazione
Archived: 2026-11-08T23:38:10.084Z
SHA-256 of the archived text: 6400637906053a4891ecaf6736bfb17998aee249fd330e40608d08a18cf03586
Stable URL of this page: https://metraipolis.com/documento/dc_aaa2297dfed0

How to cite

Long-Term Safety Profile of Ruxolitinib in Chronic Myeloproliferative Neoplasms: A Comprehensive Real-World Analysis — Europe PMC PMID:41169484 — Europe PMC (en), https://europepmc.org/article/MED/41169484 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aaa2297dfed0 (Metraipolis archive dc_aaa2297dfed0, sha256 6400637906053a4891ecaf6736bfb17998aee249fd330e40608d08a18cf03586)

BibTeX

@misc{dcaaa2297dfed0,
  title = {Long-Term Safety Profile of Ruxolitinib in Chronic Myeloproliferative Neoplasms: A Comprehensive Real-World Analysis — Europe PMC PMID:41169484},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41169484},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aaa2297dfed0; sha256 6400637906053a4891ecaf6736bfb17998aee249fd330e40608d08a18cf03586},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41169484. Agents can read the archived copy with the MCP tool read_document.